SAN ANTONIO – A new study from UT Health San Antonio has provided new insights into Alzheimer’s disease. Researchers have uncovered a genetic factor that may contribute to the risk of late onset of ...

Annovis Bio has commenced the treatment of first two subjects in a randomised Phase III clinical trial to assess the efficacy and safety of buntanetap in treating early Alzheimer's disease (AD). The ...